Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Leadership
Board of Directors
Scientific Advisors (DMD)
Our Science
Deramiocel (Biologic Medicine)
Exosomes Technology
Publications
Strategic Partnerships
Pipeline
Pipeline
Duchenne Muscular Dystrophy Overview
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact
Section 16 Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
In the News
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Leadership
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Latest Proxy Statement and Annual Report
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
3
3/A
4
4/A
5
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Date
Form
Description
PDF
XBRL
Pages
08/21/06
3
Initial statement of beneficial ownership of securities
1
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
22
Page
23
Page
24
Page
25
Page
26
Page
27
Page
28
Page
29
Page
30
Page
31
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Email Alerts
Company Profile
Contacts
RSS News Feed